Favorable Press Coverage Extremely Likely to Impact GETINGE AB/ADR (GNGBY) Share Price
News headlines about GETINGE AB/ADR (OTCMKTS:GNGBY) have trended positive this week, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by monitoring more than 6,000 news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. GETINGE AB/ADR earned a media sentiment score of 2.50 on their scale. InfoTrie also assigned press coverage about the company an news buzz score of 10 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company’s share price in the next several days.
Shares of GNGBY stock opened at $9.48 on Friday. The stock has a market capitalization of $2.50 billion, a PE ratio of 22.39 and a beta of 1.66. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.60 and a quick ratio of 1.55. GETINGE AB/ADR has a one year low of $8.31 and a one year high of $19.30.
Separately, ValuEngine downgraded shares of GETINGE AB/ADR from a “hold” rating to a “sell” rating in a report on Monday, October 8th.
About GETINGE AB/ADR
Getinge AB provides products and services for surgery, intensive-care, long-term care, infection control, and sterilization in Sweden and internationally. The company operates through Acute Care Therapies, Patient & Post-Acute Care, and Surgical Workflows segments. It offers infection control systems for hospitals under the Getinge and Maquet brands; equipment for complete surgical workplaces and expanded treatment options; equipment, consumables, and services for cleaning, disinfection and sterilization of instruments; and IT tracking systems.
Featured Article: What does relative strength index mean?
Receive News & Ratings for GETINGE AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GETINGE AB/ADR and related companies with MarketBeat.com's FREE daily email newsletter.